UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 557

Sortiert nach

A War on Two Fronts: Cancer Care in the Time of COVID-19

Annals of internal medicine, 2020-06, Vol.172 (11), p.756

2020

Volltextzugriff (PDF)

Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung

Journal of clinical oncology, 2017-02, Vol.35 (4), p.412-420

2017

Volltextzugriff (PDF)

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2191-2197

2010

Volltextzugriff (PDF)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors

Advances in therapy, 2019-10, Vol.36 (10), p.2638-2678

2019

Volltextzugriff (PDF)

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

Annals of oncology, 2014-09, Vol.25 (9), p.1681-1690

2014

Volltextzugriff (PDF)

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3320-3326

2013

Volltextzugriff (PDF)

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing

International journal of molecular sciences, 2023-11, Vol.24 (21), p.15779

2023

Volltextzugriff (PDF)

Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy

Clinical cancer research, 2017-10, Vol.23 (19), p.5948-5958

2017

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2063-2069

2012

Volltextzugriff (PDF)

50 Years of progress in the systemic therapy of non-small cell lung cancer

American Society of Clinical Oncology educational book, 2014 (34), p.177-189

2014

Volltextzugriff (PDF)

American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2022-02, Vol.112 (2), p.361

2022

Volltextzugriff (PDF)

Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the Lung

International journal of radiation oncology, biology, physics, 2012-10, Vol.84 (2), p.456-463

2012

Volltextzugriff (PDF)

GP88 (progranulin): a novel tissue and circulating biomarker for non–small cell lung carcinoma

Human pathology, 2014-09, Vol.45 (9), p.1893-1899

2014

Volltextzugriff (PDF)

Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy

The oncologist (Dayton, Ohio), 2017-06, Vol.22 (6), p.737-742

2017

Volltextzugriff (PDF)

SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.1853-1859

2019

Volltextzugriff (PDF)

Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic

Journal of thoracic oncology, 2020-07, Vol.15 (7), p.1137-1146

2020

Volltextzugriff (PDF)

Prophylactic Cranial Irradiation for Small-Cell Lung Cancer: Time for a Reassessment

American Society of Clinical Oncology educational book, 2020-05, Vol.40 (40), p.24-28

Edelman, Martin J

2020

Volltextzugriff (PDF)

The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A Review

International journal of radiation oncology, biology, physics, 2020-09, Vol.108 (1), p.38-45

2020

Volltextzugriff (PDF)

Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Clinical cancer research, 2013-07, Vol.19 (13), p.3567-3576

2013

Volltextzugriff (PDF)

Validation of Disability Status, a Claims-based Measure of Functional Status for Cancer Treatment and Outcomes Studies

Medical care, 2014-06, Vol.52 (6), p.500-510

2014

Volltextzugriff (PDF)

New Therapies in Special Populations

JCO oncology practice, 2020-06, Vol.16 (6), p.329-330

Edelman, Martin J

2020

Volltextzugriff (PDF)

A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells

Nature communications, 2015-06, Vol.6 (1), p.7316-7316, Article 7316

2015

Volltextzugriff (PDF)

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2184-2192

2017

Volltextzugriff (PDF)

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials

Journal of clinical oncology, 2008-01, Vol.26 (3), p.463-467

2008

Volltextzugriff (PDF)

Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation

Lung cancer (Amsterdam, Netherlands), 2019-09, Vol.135, p.16-20

2019

Volltextzugriff (PDF)

1 – 25 von 557

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(506)
Mit Volltextzugriff
(506)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(272)
Life Sciences & Biomedicine
(257)
Humans
(245)
Oncology
(155)
Male
(140)
Female
(136)
Biological And Medical Sciences
(119)
Aged
(111)
Middle Aged
(105)
Medical Sciences
(104)
Adult
(94)
Lung Neoplasms - Drug Therapy
(81)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(68)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(68)
Lung Neoplasms - Pathology
(65)
Treatment Outcome
(58)
Neoplasm Staging
(56)
Respiratory System
(56)
Lung Cancer
(51)
Aged, 80 And Over
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A War on Two Fronts: Cancer Care in the Time of COVID-19

Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing

Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

50 Years of progress in the systemic therapy of non-small cell lung cancer

American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the Lung

GP88 (progranulin): a novel tissue and circulating biomarker for non–small cell lung carcinoma

Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy

SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic

Prophylactic Cranial Irradiation for Small-Cell Lung Cancer: Time for a Reassessment

The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A Review

Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Validation of Disability Status, a Claims-based Measure of Functional Status for Cancer Treatment and Outcomes Studies

New Therapies in Special Populations

A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials

Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation

Suchergebnisse filtern